---
title: Machine learning and biological validation identify sphingolipids as potential
  mediators of paclitaxel-induced neuropathy in cancer patients
date: '2024-09-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39347767/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240930184655&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Present findings suggest a role for sphinganine-1-phosphate
  in paclitaxel-induced biological changes associated with neuropathic side effects.
  The identified SA1P, through its receptors, may provide a potential drug target
  for co-therapy with paclitaxel to reduce one of its major and therapy-limiting side
  ...'
disable_comments: true
---
CONCLUSIONS: Present findings suggest a role for sphinganine-1-phosphate in paclitaxel-induced biological changes associated with neuropathic side effects. The identified SA1P, through its receptors, may provide a potential drug target for co-therapy with paclitaxel to reduce one of its major and therapy-limiting side ...